Cross-contamination in routine diagnostic in the mycobacteriology laboratories – risk factors, detection and prevention

Journal Title: Postępy Nauk Medycznych - Year 2015, Vol 28, Issue 4

Abstract

Introduction. Identification of Mycobacterium tuberculosis complex in clinical material from the patient is the basis of microbiological confirmation of TB, and remains gold standard for diagnosis. The results of numerous studies show that about 0.1-4% derived culture may be the result of cross-contamination. It occurs most frequently during processes of collection and processing of clinical samples, as a result of infection during medical procedures.Aim. Determining the incidence of cross-contamination in the National Tuberculosis Reference Laboratory during 2011-June 2014.Material and methods. The material for the study were 598 isolates of Mycobacterium tuberculosis complex from 408 patients with suspected tuberculosis. For the epidemiological and molecular analysis we selected 26 (4.3%) cultures, which, according to the CDC guidelines, could be potentially false-positive. The information that determined the choice of strains is the same date of inoculation and the sequence number of the study or in close proximity to the material from which the culture was obtained. Molecular analysis of the strains was performed using spoligotyping and MIRU-VNTR methods.Results. We examined 12 potential cross-contamination incidents. Finally, contamination was confirmed in 4 cases. The consequence was to obtain 5 (0.8%) false-positive cultures of M. tuberculosis complex.Conclusions. Detection of cross-contamination of materials from patients with suspected tuberculosis has epidemiological, clinical and therapeutic significance. Proper system of monitoring and identification of false positive cultures requires reliable medical documentation and using appropriate genotyping methods.

Authors and Affiliations

Monika Kozińska, Katarzyna Wasiak, Magdalena Klatt, Ewa Augustynowicz-Kopeć

Keywords

Related Articles

Genotypowanie M. kansasii metodą TRS-PCR

Wstęp. W ostatnich latach obserwowany jest wzrost zachorowań wywoływanych przez prątki należące do grupy NTM, w tym Mycobacterium kansasii. Z tego względu ważne jest znalezienie odpowiedniej metody, która pozwoli na anal...

Profilaktyka i leczenie hiperhomocysteinemii

Homocysteina (Hcys) jest niebiałkowym aminokwasem będącym metabolitem pośrednim na szlakach przemiany metioniny. Podwyższone stężenie homocysteiny (> 15 µM, tzw. hyperhomocysteinemia) jest skorelowane z występowan...

Potencjalne czynniki etiologiczne u pacjentów z uporczywym świądem odbytu

Wstęp. Świąd odbytu to najczęstsza dolegliwość dermatologiczna okolicy anogenitalnej. Badania epidemiologiczne dotyczące czynników predysponujących dla tej dolegliwości są rzadkie. Występuje on u około 1-5% populacji, cz...

Hereditary breast and ovarian cancer

Familial breast cancer was first recognized in the Roman medical literature of 100 AD (1). The first documentation of familial clustering of breast cancer in modern times was published by Broca, who reported 10 cases of...

Flow-diverters in endovascular treatment of unruptured brain aneurysm

Endovascular techniques of brain aneurysms treatment developed significantly during past decades. The traditional coiling approach was extended by use of stents or occlusion balloons. A new treatment philosophy was also...

Download PDF file
  • EP ID EP55021
  • DOI -
  • Views 190
  • Downloads 0

How To Cite

Monika Kozińska, Katarzyna Wasiak, Magdalena Klatt, Ewa Augustynowicz-Kopeć (2015). Cross-contamination in routine diagnostic in the mycobacteriology laboratories – risk factors, detection and prevention. Postępy Nauk Medycznych, 28(4), 228-234. https://europub.co.uk/articles/-A-55021